Kratos Q2 FY26 adjusted EPS rises 90.91% to $0.21; revenue climbs 30.5% to $458.8 million
KTOS•Quarterly results
- Kratos posted Q2 2026 revenue of $458.8 million, up 30.5% year over year; GAAP net income was $4.4 million, up from $2.9 million.
- GAAP operating results swung to a $1.6 million loss from $3.7 million operating income a year earlier; GAAP diluted EPS held at $0.02.
- Non-GAAP adjusted EBITDA rose to $38.2 million from $28.3 million; non-GAAP adjusted EPS increased to $0.21 from $0.11.
Bookings, backlog and guidance
- Q2 consolidated bookings were $492.2 million with a book-to-bill ratio of 1.1; backlog ended the quarter at $2.08 billion.
- Full-year 2026 revenue guidance increased to $1.75 billion-$1.81 billion; Q3 revenue forecast was $460 million-$480 million.
Related News
International Stem Cell board backs USD 25 million sale of Lifeline Cell Technology to ATCC
ISCO•
Equitable Q2 FY26 net loss widens to $453 million; non-GAAP operating earnings per share rise 54.55% to $1.70
EQH•
